| |
|
|
|
Aerpio Pharmaceuticals Inc  
|
|
1.28 -0.06 (-0.04%) |
10-26 16:00 |
|
Open: |
1.34 |
Pre close: |
1.34 |
Target:
|
1.84
|
|
High: |
1.3501 |
Low: |
1.25 |
Resistance:
|
1.57
1.79
|
|
Volume: |
3,454,754 |
Market Cap: |
54M |
Support:
|
1.22
1.02
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.32
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
1.40 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
1.37  |
Stochastic Oscillator |
%K(14,3):
|
30.52 |
|
MA(250): |
0.93 |
%D(3): |
23.09 |
|
Average Volume(K) |
3-Month: |
215260
|
52-Week |
High:
|
1.90 |
|
10-Days: |
103489 |
Low: |
0.42 |
|
RSI |
RSI(14):
|
40.32 |
Change(%): |
142.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.093 |
Return on Equity (ttm) |
-8.5 |
Shares Out. (M) |
42.07 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-4.6 |
Shares Float (M) |
27.71 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
24.32 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
27.22 |
|
Forward EPS |
-0.310 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
800 |
|
Book Value (p.s.) |
1.050 |
EBITDA (p.s.) |
-0.082 |
P/E |
-13.76 |
|
Sales Per Share |
0.357 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.22 |
|
Profit Margin |
-24.91 |
Operating Cash Flow
(M) |
-3.28 |
P/S |
3.59 |
|
Operating Margin |
-23.56 |
Levered Free Cash Flow
(M) |
-2.00 |
P/CF |
-16.42 |
|
|
|
|
|
|
